Cincinnati Children's News Releases

The Public Relations staff in the Marketing and Communications Department at Cincinnati Children's Hospital Medical Center is committed to providing the news media and families with the latest news and highlights about Cincinnati Children's and its efforts to improve children's health.

Recent News Releases

Thursday, September 11, 2014 - Cincinnati Children’s Puts Visitor Restrictions in Place

Medical Center Takes Precautionary Measure Due to Increased Number of Respiratory Patients at Hospital.

Wednesday, September 10, 2014 - $1 Million Grant to Cincinnati Children’s Intended to Improve Human Growth and Development Around the World

Why is it harder for kids in low- and middle-income countries to grow as well as kids in wealthy countries? Food security, or access to good nutrition, remains a major challenge. The issue is not just food supply but poor sanitation - a problem exacerbated by local infrastructure and cultural mores.

Thursday, September 04, 2014 - Study IDs Gene Network Behind Untreatable Leukemia and Possible Treatment Target

Researchers have identified a genetic/molecular network that fuels a high-risk and aggressive form of Acute Myeloid Leukemia (AML) and its precursor disease Myelodysplastic Syndrome (MDS) – providing a possible therapeutic strategy for an essentially untreatable form of the blood cancer. Scientists from the Cancer and Blood Diseases Institute (CBDI) at Cincinnati Children’s Hospital Medical Center report their results in a study posted online Sept. 4 by Cell Reports. 

Monday, August 25, 2014 - Cincinnati Children’s to Provide Healthcare to Neighborhood Schools

Cincinnati Children’s Hospital Medical Center has been selected by South Avondale and Rockdale elementary schools, Hughes High School, and their local school decision-making committees to provide school-based healthcare for children and teens starting this school year.

Sunday, August 24, 2014 - Study Suggests Repurposing Anti-depressant Medication to Target Medulloblastoma

An international research team reports in Nature Medicine a novel molecular pathway that causes an aggressive form of medulloblastoma, and suggests repurposing an anti-depressant medication to target the new pathway may help combat one of the most common brain cancers in children.